細胞と遺伝子の調査レビュー　2024年

Report Highlights

• The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
• The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a CAGR of 11.5% during the forecast period of 2024 to 2029.
• The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a CAGR of 15.8% from 2023 through 2028.

Research Review Scope:

Cell and gene therapy is a vast industry that uses cells and genes in research, development, manufacture, and distribution to treat diseases. Cells and genes can be utilized in preclinical studies, clinical trials, the production of therapies, viral vectors, modified cells, and personalized medicine.

細胞と遺伝子治療は、疾患治療のために細胞と遺伝子を研究、開発、製造、流通に利用する巨大な産業です。細胞と遺伝子は、前臨床研究、臨床試験、治療薬の製造、ウイルスベクター、改変細胞、個別化医療などに活用されます。

One of the major factors in this market’s growth is the increasing investment and funding. The rapid growth in research and development of new cell and gene therapies, along with a new level of innovation, also fuels the growth of this market. However, the high cost of developing these therapies restrains the market’s growth.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of Cell and Gene Therapy provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

– BIO208C Cell and Gene Therapy Tools, and Reagents: Global Markets.

– BIO211B Cell Therapy Biomanufacturing: Global Markets.

– BIO251A Gene Synthesis: Technologies and Global Markets.

– BIO258A Global Automated and Closed Cell Therapy Market.

– BIO225B Global Market for Cell and Gene Therapy.

– BIO256A Global Live Cell Imaging Market.

– BIO257A Global Single-cell Technologies Market.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

Research Review Scope

Chapter 2 Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)

Scope of Report of Cell and Gene Therapy Tools, and Reagents

Market Summary of Cell and Gene Therapy Tools, and Reagents

Market Overview of Cell and Gene Therapy Tools, and Reagents

Approved CGT Products

Market Dynamics of Cell and Gene Therapy Tools, and Reagents

Market Drivers

Market Restraints

Market Opportunities

Market Segmentation Analysis of Cell and Gene Therapy Tools, and Reagents

Segmentation Breakdown of Cell and Gene Therapy Tools, and Reagents

Global Market for CGT Tools and Reagents, by Product

Immunoassays

Bioreactors

Leukapheresis

GMP Antibodies

Multiplex Immunoassays

Vectors

Cell Separation

Cryopreservation

Cell Expansion

Media

GMP Proteins

GMP Small Molecules

CRS Monitoring

Global Market for CGT Tools and Reagents, by Application

Cancer

Rare Diseases

Other Diseases

Global Market for CGT Tools and Reagents, by End User

Pharmaceutical and Biotech Companies

Academic and Research Institutes

Clinical Laboratories

Geographic Breakdown

Global Market for CGT Tools and Reagents, by Region

North America

Europe

Asia-Pacific

Rest of the World

Emerging Technologies and Developments of Cell and Gene Therapy Tools, and Reagents

Closed and Automated Systems

Single-Use Technologies

Sustainability in the CGT Tool and Reagent Market: ESG Perspective

Introduction to ESG

ESG Performance in the Industry

ESG Practices in the CGT Tool and Reagent Industry

Environmental Performance

Social Performance

Governance Performance

Concluding Remarks from BCC Research

Chapter 3 Cell Therapy Biomanufacturing: Global Markets (BIO211B)

Scope of Report of Cell Therapy Biomanufacturing

Market Summary of Cell Therapy Biomanufacturing

Market Overview of Cell Therapy Biomanufacturing

Overview

Market Dynamics of Cell Therapy Biomanufacturing

Overview

Market Drivers

Market Restraints

Market Opportunities

Market Segmentation Analysis of Cell Therapy Biomanufacturing

Key Market Trends

Cell Therapy Biomanufacturing: Global Markets

Segmentation Breakdown of Cell Therapy Biomanufacturing

Market Analysis of Cell Therapy Biomanufacturing, by Product Type

Market Analysis of Cell Therapy Biomanufacturing, by Application

Skeletal Muscle Repair

Bone Repair

Cancer

Cardiovascular Diseases

Neurological Disorders

Other Diseases

Geographic Breakdown of Cell Therapy Biomanufacturing

Market Analysis of Cell Therapy Biomanufacturing, by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 4 Gene Synthesis: Technologies and Global Markets (BIO251A)

Scope of Report of Gene Synthesis

Market Summary of Gene Synthesis

Market Overview of Gene Synthesis

Overview of Gene Synthesis

Market Dynamics of Gene Synthesis

Overview

Market Drivers

Restraints

Opportunities

Challenges

Segmentation Breakdown of Gene Synthesis

Gene Synthesis: Global Market

Global Market for Gene Synthesis, by Method

Solid-phase Synthesis

PCR-based Enzyme Synthesis

Chip-based Synthesis

Global Market for Gene Synthesis, by Services

Antibody DNA Synthesis

Viral DNA Synthesis

Other Gene Synthesis Services

Gene Synthesis: Global Markets, by Application

Gene and Cell Therapy Development

Vaccine Development

Disease Diagnosis

Other Applications

Global Market for Gene Synthesis, by End User

Academic and Government Research Institutes

Biotechnology and Pharmaceutical Companies

Contract Research Organizations

Geographic Breakdown of Gene Synthesis

In-house or Outsource?

Cost Considerations

Quality Control and Assurance

Convenience and Turnaround Time

Customization and Specialization

Strategic Considerations

M&A and Venture Funding of Gene Synthesis

In Summation

Chapter 5 Global Automated and Closed Cell Therapy Market (BIO258A)

Scope of Report of Automated and Closed Cell Therapy

Market Insights of Automated and Closed Cell Therapy

Market Overview of Automated and Closed Cell Therapy

Overview

Market Dynamics of Automated and Closed Cell Therapy

Market Drivers

Market Restraints

Market Opportunities

Segmentation Breakdown of Automated and Closed Cell Therapy

Global Automated and Closed Cell Therapy Market by Automation Type

Semi-Automated Cell Therapy

Fully Automated Cell Therapy

Global Automated and Closed Cell Therapy Market by Cell Type

CAR-T Cells

Stem Cells

Other Cell Types

Global Automated and Closed Cell Therapy Market by Application

Market Size and Forecast

Clinical

Commercial

Geographic Breakdown of Automated and Closed Cell Therapy

Global Market for Automated and Closed Cell Therapy by Region

Market Size and Forecast

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 6 Global Market for Cell and Gene Therapy (BIO225B)

Scope of Report of Cell and Gene Therapy

Market Summary of Cell and Gene Therapy

Market Value of Cell and Gene Therapy

Market Overview of Cell and Gene Therapy

Cell and Gene Therapy Overview

Market Dynamics of Cell and Gene Therapy

Market Drivers

Market Restraints

Market Opportunities

Segmentation Breakdown of Cell and Gene Therapy

Global Market for Cell and Gene Therapy

Market Analysis

Cell Therapy

Market Size and Forecast

Gene-modified Cell Therapy

Market Size and Forecast

Gene Therapy

Market Forecast

Vectors Used in Gene-modified Cell Therapy and Gene Therapy

Market Analysis

Adeno-Associated Viral Vectors

Retroviral Vectors

Lentiviral Vectors

Other Vectors Used in Gene Therapy

Market Breakdown by Drug Product

Zolgensma

Yescarta

Kymriah

Abecma

Maci

Tecartus

Epicel

Other Drug Products

Market Breakdown by Application

Oncology

Rare Diseases

Ophthalmology

Other Therapeutic Areas

Geographic Breakdown of Cell and Gene Therapy

Market Breakdown of Cell and Gene Therapy by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 7 Global Live Cell Imaging Market (BIO256A)

Scope of Report of Live Cell Imaging

Market Summary of Live Cell Imaging

Market Overview of Live Cell Imaging

Overview

Market Dynamics of Live Cell Imaging

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Segmentation Breakdown of Live Cell Imaging

Market Segmentation of Live Cell Imaging by Components

Instruments and Software

Consumables

Services

Market Segmentation of Live Cell Imaging, by Technology

Time-Lapse Microscopy

Fluorescence Resonance Energy Transfer (FRET)

Fluorescence Recovery After Photobleaching (FRAP)

High-Content Screening (HCS)

Other Technologies

Market Segmentation of Live Cell Imaging by End User

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Contract Research Organizations

Geographic Breakdown of Live Cell Imaging

North America

Europe

Asia-Pacific

Rest of World

Chapter 8 Global Single-cell Technologies Market (BIO257A)

Scope of Report of Single-cell Technologies

Market Summary of Single-cell Technologies

Market Overview of Single-cell Technologies

Market Dynamics of Single-cell Technologies

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Segmentation Breakdown of Single-cell Technologies

Market Analysis of Single-cell Technologies by Product

Consumables

Instruments

Market Breakdown of Single-cell Technologies by Cell Type

Human Cells

Animal Cells

Microbial Cells

Market Breakdown by Technique

Flow Cytometry

Next-Generation Sequencing

Polymerase Chain Reaction

Microscopy

Mass Spectrometry

Other Techniques

Market Breakdown of Single-cell Technologies by Application

Research Applications

Medical Applications

Market Breakdown of Single-cell Technologies by End User

Research and Academic Laboratories

Biotechnology and Pharmaceutical Companies

Hospitals and Diagnostic Laboratories

Cell Banks and IVF Centers

Geographic Breakdown of Single-cell Technologies

Market Analysis by Region of Single-cell Technologies

North America

Europe

Asia-Pacific

Rest of the World

Chapter 9 Appendix

Methodology

Analyst’s Credentials

List of Tables

Table 1 : Global Market for CGT Tools and Reagents, by Application, Through 2029

Table 2 : Global Market for CGT Tools and Reagents, by Region, Through 2029

Table 3 : Approved CGT Products, as of 2024

Table 4 : Global Cancer Statistics, 2022

Table 5 : Global Market for CGT Tools and Reagents, by Product, Through 2029

Table 6 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029

Table 7 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029

Table 8 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029

Table 9 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029

Table 10 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029

Table 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029

Table 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029

Table 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029

Table 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029

Table 15 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029

Table 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029

Table 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029

Table 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029

Table 19 : Global Market for CGT Tools and Reagents, by Application, Through 2029

Table 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029

Table 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029

Table 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029

Table 23 : Global Market for CGT Tools and Reagents, by End User, Through 2029

Table 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029

Table 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029

Table 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029

Table 27 : Global Market for CGT Tools and Reagents, by Region, Through 2029

Table 28 : North American Market for CGT Tools and Reagents, by Product, Through 2029

Table 29 : North American Market for CGT Tools and Reagents, by Application, Through 2029

Table 30 : North American Market for CGT Tools and Reagents, by End User, Through 2029

Table 31 : European Research Initiatives Focused on Personalized Medicine

Table 32 : European Market for CGT Tools and Reagents, by Product, Through 2029

Table 33 : European Market for CGT Tools and Reagents, by Application, Through 2029

Table 34 : European Market for CGT Tools and Reagents, by End User, Through 2029

Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029

Table 36 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029

Table 37 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029

Table 38 : RoW Market for CGT Tools and Reagents, by Product, Through 2029

Table 39 : RoW Market for CGT Tools and Reagents, by Application, Through 2029

Table 40 : RoW Market for CGT Tools and Reagents, by End User, Through 2029

Table 41 : Focus Areas in ESG Metrics

Table 42 : Environmental Performance Initiatives in the CGT Tool and Reagent Market

Table 43 : Social Performance Initiatives in the CGT Tool and Reagent Market

Table 44 : Governance Performance Initiatives in the CGT Tool and Reagent Market

Table 45 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*

Table 46 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029

Table 47 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029

Table 48 : Global Market for Cell Therapy Biomanufacturing, Through 2029

Table 49 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029

Table 50 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029

Table 51 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029

Table 52 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029

Table 53 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029

Table 54 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029

Table 55 : Global Market for Gene Synthesis, Through 2028

Table 56 : Global Market for Gene Synthesis, by Services, Through 2028

Table 57 : Global Market for Gene Synthesis, Through 2028

Table 58 : Global Market for Gene Synthesis, by Method, Through 2028

Table 59 : Global Market for Solid-phase Synthesis, by Region, Through 2028

Table 60 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028

Table 61 : Global Market for Chip-based Synthesis, by Region, Through 2028

Table 62 : Global Market for Gene Synthesis, by Services, Through 2028

Table 63 : Global Market for Antibody DNA Synthesis, by Region, Through 2028

Table 64 : Global Market for Viral DNA Synthesis, by Region, Through 2028

Table 65 : Global Market for Other Synthesis Services, by Region, Through 2028

Table 66 : Global Market for Gene Synthesis, by Application, Through 2028

Table 67 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028

Table 68 : Global Market for Vaccine Development Applications, by Region, Through 2028

Table 69 : Global Market for Disease Diagnosis Applications, by Region, Through 2028

Table 70 : Global Market for Other Applications, by Region, Through 2028

Table 71 : Global Market for Gene Synthesis, by End User, Through 2028

Table 72 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028

Table 73 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028

Table 74 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028

Table 75 : Mergers and Acquisitions (M&A), 2021-2023

Table 76 : Venture Funding, 2022 and 2023

Table 77 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029

Table 78 : Differences between Semi-Automation and Full Automation in Cell Therapy

Table 79 : Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029

Table 80 : Select Semi-Automated Cell Therapy Systems

Table 81 : Global Market for Semi-Automated Cell Therapy, by Region, Through 2029

Table 82 : Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029

Table 83 : Global Market for Automated and Closed Apheresis, by Region, Through 2029

Table 84 : Global Market for Automated and Closed Expansion, by Region, Through 2029

Table 85 : Global Market for Automated and Closed Fill-Finish, by Region, Through 2029

Table 86 : Global Market for Automated and Closed Separation, by Region, Through 2029

Table 87 : Global Market for Other Automated and Closed Workflows, by Region, Through 2029

Table 88 : Global Market for Fully Automated Cell Therapy, by Region, Through 2029

Table 89 : Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029

Table 90 : FDA-Approved CAR-T Cell Therapies

Table 91 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029

Table 92 : Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029

Table 93 : Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029

Table 94 : Global Market for Automated and Closed Cell Therapy, by Application, Through 2029

Table 95 : Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029

Table 96 : Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029

Table 97 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029

Table 98 : North American Market for Automated and Closed Cell Therapy, by Country, Through 2029

Table 99 : North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029

Table 100 : North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029

Table 101 : North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029

Table 102 : North American Market for Automated and Closed Cell Therapy, by Application, Through 2029

Table 103 : European Market for Automated and Closed Cell Therapy, by Country, Through 2029

Table 104 : European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029

Table 105 : European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029

Table 106 : European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029

Table 107 : European Market for Automated and Closed Cell Therapy, by Application, Through 2029

Table 108 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029

Table 109 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029

Table 110 : Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029

Table 111 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029

Table 112 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029

Table 113 : RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029

Table 114 : RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029

Table 115 : RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029

Table 116 : RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029

Table 117 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028

Table 118 : Number of New Cases and Deaths Due to Various Cancers Globally, 2020

Table 119 : Comparison of Accelerated Approvals for Various Drugs

Table 120 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028

Table 121 : Global Market for Cell Therapy, by Region, Through 2028

Table 122 : Approved CAR-T Products, as of December 2023

Table 123 : Global Market for Gene-modified Cell Therapy, by Region, Through 2028

Table 124 : Global Market for Gene Therapy, by Region, Through 2028

Table 125 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, Through 2028

Table 126 : Global Market for Cell and Gene Therapy, by Drug Product, Through 2028

Table 127 : Global Market for Cell and Gene Therapy, by Application, Through 2028

Table 128 : Global Market for Cell and Gene Therapy for Oncology, by Region, Through 2028

Table 129 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, Through 2028

Table 130 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, Through 2028

Table 131 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, Through 2028

Table 132 : Global Market for Cell and Gene Therapy, by Region, Through 2028

Table 133 : North American Market for Cell and Gene Therapy, by Country, Through 2028

Table 134 : European Market for Cell and Gene Therapy, by Country, Through 2028

Table 135 : Asia-Pacific Market for Cell and Gene Therapy, by Country, Through 2028

Table 136 : Global Market for Live Cell Imaging, by Region, Through 2029

Table 137 : Global Market for Live Cell Imaging, by Components, Through 2029

Table 138 : Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029

Table 139 : Global Market for Live Cell Imaging Consumables, by Region, Through 2029

Table 140 : Global Market for Live Cell Imaging Services, by Region, Through 2029

Table 141 : Global Market for Live Cell Imaging, by Technology, Through 2029

Table 142 : Global Market for Time-Lapse Microscopy, by Region, Through 2029

Table 143 : Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029

Table 144 : Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029

Table 145 : Global Market for High-Content Screening, by Region, Through 2029

Table 146 : Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029

Table 147 : Global Market for Live Cell Imaging, by End User, Through 2029

Table 148 : Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029

Table 149 : A Few Academic Research Institute Using Live Cell Imaging Research

Table 150 : Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029

Table 151 : A Few Contract Research Organizations Using Live Cell Imaging

Table 152 : Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029

Table 153 : Global Market for Live Cell Imaging, by Region, Through 2029

Table 154 : North American Market for Live Cell Imaging, by Country, Through 2029

Table 155 : North American Market for Live Cell Imaging, by Components, Through 2029

Table 156 : North American Market for Live Cell Imaging, by Technology, Through 2029

Table 157 : North American Market for Live Cell Imaging, by End User, Through 2029

Table 158 : U.S. Market for Live Cell Imaging, Through 2029

Table 159 : Canadian Market for Live Cell Imaging, Through 2029

Table 160 : Mexican Market for Live Cell Imaging, Through 2029

Table 161 : European Market for Live Cell Imaging, by Country, Through 2029

Table 162 : European Market for Live Cell Imaging, by Components, Through 2029

Table 163 : European Market for Live Cell Imaging, by Technology, Through 2029

Table 164 : European Market for Live Cell Imaging, by End User, Through 2029

Table 165 : German Market for Live Cell Imaging, Through 2029

Table 166 : U.K. Market for Live Cell Imaging, Through 2029

Table 167 : French Market for Live Cell Imaging, Through 2029

Table 168 : Spanish Market for Live Cell Imaging, Through 2029

Table 169 : Italian Market for Live Cell Imaging, Through 2029

Table 170 : Rest of European Market for Live Cell Imaging, Through 2029

Table 171 : Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029

Table 172 : Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029

Table 173 : Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029

Table 174 : Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029

Table 175 : Chinese Market for Live Cell Imaging, Through 2029

Table 176 : Japanese Market for Live Cell Imaging, Through 2029

Table 177 : Indian Market for Live Cell Imaging, Through 2029

Table 178 : South Korean Market for Live Cell Imaging, Through 2029

Table 179 : Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029

Table 180 : Rest of the World Market for Live Cell Imaging, by Components, Through 2029

Table 181 : Rest of the World Market for Live Cell Imaging, by Technology, Through 2029

Table 182 : Rest of the World Market for Live Cell Imaging, by End User, Through 2029

Table 183 : Global Market for Single-Cell Technologies, by Product, Through 2029

Table 184 : Assay Kits Offered by 10X Genomics

Table 185 : Global Market for Single-Cell Technologies Consumables, by Region, Through 2029

Table 186 : Single-Cell Technologies Flow Cytometry Systems, by Company

Table 187 : Single-Cell Technologies NGS Systems, by Company

Table 188 : Single-Cell Technologies PCR Systems, by Company

Table 189 : Single-Cell Technologies Mass Spectrophotometers, by Company

Table 190 : Single-Cell Technologies Microscopes, by Company

Table 191 : Global Market for Single-Cell Technologies Instruments, by Region, Through 2029

Table 192 : Global Market for Single-Cell Technologies, by Cell Type, Through 2029

Table 193 : Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029

Table 194 : Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029

Table 195 : Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029

Table 196 : Global Market for Single-Cell Technologies, by Technique, Through 2029

Table 197 : Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029

Table 198 : Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029

Table 199 : Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029

Table 200 : Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029

Table 201 : Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029

Table 202 : Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029

Table 203 : Global Market for Single-Cell Technologies, by Application, Through 2029

Table 204 : Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029

Table 205 : Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029

Table 206 : Global Market for Single-Cell Technologies, by End User, Through 2029

Table 207 : Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029

Table 208 : Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029

Table 209 : Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029

Table 210 : Stem Cell Banks and Registries Worldwide, by Country

Table 211 : Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029

Table 212 : Global Market for Single-Cell Technologies, by Region, Through 2029

List of Figures

Figure 1 : Global Market for CGT Tools and Reagents, by Application, 2021-2029

Figure 2 : Global Market for CGT Tools and Reagents, by Region, 2021-2029

Figure 3 : Market Dynamics of CGT Tools and Reagents

Figure 4 : CGT Sector Investments, 2018-2023

Figure 5 : CGT Sector Investments, by Deal Type, Q1 2024

Figure 6 : Global Market Shares of CGT Tools and Reagents, by Product, 2024

Figure 7 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029

Figure 8 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029

Figure 9 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029

Figure 10 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029

Figure 11 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029

Figure 12 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022

Figure 13 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029

Figure 14 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029

Figure 15 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029

Figure 16 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029

Figure 17 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029

Figure 18 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029

Figure 19 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029

Figure 20 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029

Figure 21 : Global Market Shares of CGT Tools and Reagents, by Application, 2024

Figure 22 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029

Figure 23 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029

Figure 24 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029

Figure 25 : Global Market Shares of CGT Tools and Reagents, by End User, 2024

Figure 26 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029

Figure 27 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029

Figure 28 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029

Figure 29 : Global Market Shares of CGT Tools and Reagents, by Region, 2024

Figure 30 : North American Market for CGT Tools and Reagents, by Product, 2021-2029

Figure 31 : North American Market for CGT Tools and Reagents, by Application, 2021-2029

Figure 32 : North American Market for CGT Tools and Reagents, by End User, 2021-2029

Figure 33 : European Market for CGT Tools and Reagents, by Product, 2021-2029

Figure 34 : European Market for CGT Tools and Reagents, by Application, 2021-2029

Figure 35 : European Market for CGT Tools and Reagents, by End User, 2021-2029

Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029

Figure 37 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029

Figure 38 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029

Figure 39 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029

Figure 40 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029

Figure 41 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029

Figure 42 : How a Strong ESG Proposition Benefits Businesses

Figure 43 : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029

Figure 44 : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029

Figure 45 : Market Dynamics of Cell Therapy Biomanufacturing

Figure 46 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023

Figure 47 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023

Figure 48 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023

Figure 49 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023

Figure 50 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023

Figure 51 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023

Figure 52 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023

Figure 53 : Global Market for Gene Synthesis, by Services, 2020-2028

Figure 54 : Market Dynamics of Gene Synthesis

Figure 55 : Global Market Shares for Gene Synthesis, by Method, 2022

Figure 56 : Global Market Shares for Gene Synthesis, by Services, 2022

Figure 57 : Global Market Shares for Gene Synthesis, by Application, 2022

Figure 58 : Global Market Shares for Gene Synthesis, by End User, 2022

Figure 59 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023

Figure 60 : Market Dynamics of Global Automated and Closed Cell Therapy Market

Figure 61 : Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023

Figure 62 : Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029

Figure 63 : Global Market for Fully Automated Cell Therapy, by Region, 2021-2029

Figure 64 : Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023

Figure 65 : Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029

Figure 66 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029

Figure 67 : Global Market for Automated and Closed Stem Cell Therapy, 2021-2029

Figure 68 : Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029

Figure 69 : Global Market for Automated and Closed Other Cell Therapies, 2021-2029

Figure 70 : Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029

Figure 71 : Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023

Figure 72 : Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029

Figure 73 : Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029

Figure 74 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023

Figure 75 : Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029

Figure 76 : North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023

Figure 77 : U.S. Market for Automated and Closed Cell Therapy, 2021-2029

Figure 78 : Canadian Market for Automated and Closed Cell Therapy, 2021-2029

Figure 79 : Mexican Market for Automated and Closed Cell Therapy, 2021-2029

Figure 80 : European Market Shares of Automated and Closed Cell Therapy, by Country, 2023

Figure 81 : German Market for Automated and Closed Cell Therapy, 2021-2029

Figure 82 : French Market for Automated and Closed Cell Therapy, 2021-2029

Figure 83 : Italian Market for Automated and Closed Cell Therapy, 2021-2029

Figure 84 : Spanish Market for Automated and Closed Cell Therapy, 2021-2029

Figure 85 : U.K. Market for Automated and Closed Cell Therapy, 2021-2029

Figure 86 : Rest of European Market for Automated and Closed Cell Therapy, 2021-2029

Figure 87 : Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023

Figure 88 : Chinese Market for Automated and Closed Cell Therapy, 2021-2029

Figure 89 : Japanese Market for Automated and Closed Cell Therapy, 2021-2029

Figure 90 : Indian Market for Automated and Closed Cell Therapy, 2021-2029

Figure 91 : Australian Market for Automated and Closed Cell Therapy, 2021-2029

Figure 92 : South Korean Market for Automated and Closed Cell Therapy, 2021-2029

Figure 93 : Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029

Figure 94 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028

Figure 95 : Cell and Gene Therapy Market Dynamics

Figure 96 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028

Figure 97 : Global Market Shares of Cell and Gene Therapy, by Type of Therapy, 2022

Figure 98 : Global Market for Cell Therapy, by Region, 2020-2028

Figure 99 : Global Market for Gene-modified Cell Therapy, by Region, 2020-2028

Figure 100 : Global Market for Gene Therapy, by Region, 2020-2028

Figure 101 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2020-2028

Figure 102 : Global Market Shares of Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2022

Figure 103 : Global Market for AAV Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028

Figure 104 : Global Market for Retroviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028

Figure 105 : Global Market for Lentiviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028

Figure 106 : Global Market for Other Vectors Used in Gene-modified Cell Therapy and Gene Therapy, 2020-2028

Figure 107 : Global Market for Cell and Gene Therapy, by Drug Product, 2020-2028

Figure 108 : Global Market Shares of Cell and Gene Therapy, by Drug Product, 2022

Figure 109 : Global Market for Zolgensma for Cell and Gene Therapy, 2020-2028

Figure 110 : Global Market for Yescarta for Cell and Gene Therapy, 2020-2028

Figure 111 : Global Market for Kymriah for Cell and Gene Therapy, 2020-2028

Figure 112 : Global Market for Abecma for Cell and Gene Therapy, 2020-2028

Figure 113 : Global Market for Maci for Cell and Gene Therapy, 2020-2028

Figure 114 : Global Market for Tecartus for Cell and Gene Therapy, 2020-2028

Figure 115 : Global Market for Epicel for Cell and Gene Therapy, 2020-2028

Figure 116 : Global Market for Other Types of Drugs Used in Drugs Cell and Gene Therapy, 2020-2028

Figure 117 : Global Market for Cell and Gene Therapy, by Application, 2020-2028

Figure 118 : Global Market Shares of Cell and Gene Therapy, by Application, 2022

Figure 119 : Global Market Cell and Gene Therapy for Oncology, by Region, 2020-2028

Figure 120 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, 2020-2028

Figure 121 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, 2020-2028

Figure 122 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, 2020-2028

Figure 123 : Global Market for Cell and Gene Therapy, by Region, 2020-2028

Figure 124 : Global Market Shares of Cell and Gene Therapy, by Region, 2022

Figure 125 : North American Market Shares of Cell and Gene Therapy, by Country, 2022

Figure 126 : U.S. Market for Cell and Gene Therapy, 2020-2028

Figure 127 : Canadian Market for Cell and Gene Therapy, 2020-2028

Figure 128 : Mexican Market for Cell and Gene Therapy, 2020-2028

Figure 129 : European Market Shares of Cell and Gene Therapy, by Country, 2022

Figure 130 : German Market for Cell and Gene Therapy, 2020-2028

Figure 131 : U.K. Market for Cell and Gene Therapy, 2020-2028

Figure 132 : French Market for Cell and Gene Therapy, 2020-2028

Figure 133 : Rest of European Market for Cell and Gene Therapy, 2020-2028

Figure 134 : Asia-Pacific Market Shares of Cell and Gene Therapy, by Country, 2022

Figure 135 : Japanese Market for Cell and Gene Therapy, 2020-2028

Figure 136 : Chinese Market for Cell and Gene Therapy, 2020-2028

Figure 137 : Australian Market for Cell and Gene Therapy, 2020-2028

Figure 138 : Rest of Asia-Pacific Market for Cell and Gene Therapy, 2020-2028

Figure 139 : RoW Market for Cell and Gene Therapy, 2020-2028

Figure 140 : Global Market for Live Cell Imaging, by Region, 2021-2029

Figure 141 : Market Dynamics of Global Live Cell Imaging Market

Figure 142 : Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025

Figure 143 : Global Market Shares of Live Cell Imaging, by Components, 2023

Figure 144 : Global Market Shares of Live Cell Imaging, by Technology, 2023

Figure 145 : Global Market Shares of Live Cell Imaging, by End-user, 2023

Figure 146 : Global Market Shares of Live Cell Imaging, by Region, 2023

Figure 147 : North American Market Shares of Live Cell Imaging, by Country, 2023

Figure 148 : North American Market for Live Cell Imaging, by Components, 2021-2029

Figure 149 : North American Market for Live Cell Imaging, by Technology, 2021-2029

Figure 150 : North American Market for Live Cell Imaging, by End User, 2021-2029

Figure 151 : U.S. Market for Live Cell Imaging, 2021-2029

Figure 152 : Canadian Market for Live Cell Imaging, 2021-2029

Figure 153 : Mexican Market for Live Cell Imaging, 2021-2029

Figure 154 : European Market Shares of Live Cell Imaging, by Country, 2023

Figure 155 : European Market for Live Cell Imaging, by Components, 2021-2029

Figure 156 : European Market for Live Cell Imaging, by Technology, 2021-2029

Figure 157 : European Market for Live Cell Imaging, by End User, 2021-2029

Figure 158 : German Market for Live Cell Imaging, 2021-2029

Figure 159 : U.K. Market for Live Cell Imaging, 2021-2029

Figure 160 : French Market for Live Cell Imaging, 2021-2029

Figure 161 : Spanish Market for Live Cell Imaging, 2021-2029

Figure 162 : Italian Market for Live Cell Imaging, 2021-2029

Figure 163 : Rest of European Market for Live Cell Imaging, 2021-2029

Figure 164 : Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023

Figure 165 : Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029

Figure 166 : Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029

Figure 167 : Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029

Figure 168 : Chinese Market for Live Cell Imaging, 2021-2029

Figure 169 : Japanese Market for Live Cell Imaging, 2021-2029

Figure 170 : Indian Market for Live Cell Imaging, 2021-2029

Figure 171 : South Korean Market for Live Cell Imaging, 2021-2029

Figure 172 : Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029

Figure 173 : Rest of the World Market for Live Cell Imaging, by Components, 2021-2029

Figure 174 : Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029

Figure 175 : Rest of the World Market for Live Cell Imaging, by End User, 2021-2029

Figure 176 : Global Market for Single-Cell Technologies, by Product, 2021-2029

Figure 177 : Market Dynamics of Single-Cell Technologies

Figure 178 : Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050

Figure 179 : Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022

Figure 180 : Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019

Figure 181 : Global Market Shares of Single-Cell Technologies, by Product, 2023

Figure 182 : Global Market Shares of Single-Cell Technologies, by Cell Type, 2023

Figure 183 : Global Market Shares of Single-Cell Technologies, by Technique, 2023

Figure 184 : Cost for Sequencing a Human Genome, November 2017–May 2022

Figure 185 : Global Market Shares of Single-Cell Technologies, by Application, 2023

Figure 186 : Global Market Shares of Single-Cell Technologies, by End User, 2023

Figure 187 : Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies

Figure 188 : Global Market Shares of Single-Cell Technologies, by Region, 2023

Figure 189 : U.S. NIH Funding for Genome Research, 2021-2023

Figure 190 : North American Market for Single-Cell Technologies, 2021-2029

Figure 191 : European Market for Single-Cell Technologies, 2021–2029

Figure 192 : Asia-Pacific Market for Single-Cell Technologies, 2021-2029

Figure 193 : Rest of the World Market for Single-Cell Technologies, 2021-2029

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 不織布ろ材の世界市場 2025-05-07
• 世界のグリーンスチール市場 2025-05-05
• デジタルパソロジーの技術と世界市場 2025-04-29
• 持続可能エネルギーの調査レビュー　2024年 2025-04-22
• 世界の燃料電池スタック市場 2025-04-22

BCC Research  出版レポート一覧